MACC1 expression levels as a novel prognostic marker for colorectal cancer Journal Article


Authors: Yamamoto, H.; Miyoshi, N.; Mimori, K.; Hitora, T.; Tokuoka, M.; Fujino, S.; Ellis, H. L.; Ishii, H.; Noura, S.; Ohue, M.; Yano, M.; Doki, Y.; Mori, M.
Article Title: MACC1 expression levels as a novel prognostic marker for colorectal cancer
Abstract: Metastasis-associated in colon cancer-1 (MACC1) is key in promoting tumor proliferation and invasion, and is mediated by the hepatocyte growth factor (HGF) and mesenchymal-epithelial transition factor. Previous reports have revealed that MACC1 is a novel oncogene that is expressed in various types of gastrointestinal cancer. The present study comprised of 174 patients who underwent curative surgery for colorectal cancer (CRC). The correlation between gene expression and clinical parameters of the patients was assessed. It was identified that patients exhibiting high MACC1 expression levels were statistically more susceptible to distant metastases and a poor prognosis, and those exhibiting low MACC1 expression showed improved disease-free and overall survival than those with high expression. Therefore, the present data indicates that MACC1 expression levels may present as a prognostic factor in CRC patients.
Keywords: colorectal cancer; prognosis; metastasis-associated in colon cancer-1
Journal Title: Oncology Letters
Volume: 8
Issue: 5
ISSN: 1792-1074
Publisher: Spandidos Publications  
Date Published: 2014-11-01
Start Page: 2305
End Page: 2309
Language: English
DOI: 10.3892/ol.2014.2460
PROVIDER: scopus
PMCID: PMC4186624
PUBMED: 25295116
DOI/URL:
Notes: Export Date: 1 October 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Haley Lynn Ellis
    7 Ellis